StageZero Life Sciences Ltd.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- James R. Howard-Tripp
- Full Time Employees
- 40
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 70 East Beaver Creek Road Richmond Hill ON Canada L4B 3B2
- IPO Date
- Sep 8, 2009
- CIK
- 0001454263
- Website
- stagezerolifesciences.com
- Similar Companies
- Business
- StageZero Life Sciences Ltd. is a vertically integrated healthcare company focused on early detection and management of cancer and chronic diseases through proprietary molecular diagnostic tests and telehealth programs. The company develops and commercializes products including its lead mRNA-based multi-cancer panel test Aristotle, which detects molecular signatures of nine specific cancers—ovarian, breast, endometrial, cervical, bladder, prostate, colorectal, liver, and stomach—from a single blood sample; ColonSentry, a blood-based colorectal cancer risk assessment test; AVRT, a personalized risk assessment program targeting inflammatory and metabolic pathways to prevent cancer through lifestyle interventions; and the COC Protocol, an adjunctive telehealth intervention for cancer patients. Its patented Sentinel Principle platform identifies RNA biomarkers from whole blood, validated in over 9,000 patients and used by more than 100,000 in North America. Founded in 1997 and headquartered in Richmond Hill, Canada, with U.S. laboratory operations in Richmond, Virginia, StageZero targets self-funded health plans, employers, and individuals in North America and Western Europe, offering comprehensive services from screening to clinical interventions via physicians and phlebotomists. Recent developments include a partial revocation of a cease trade order in May 2025 tied to delayed 2023 financial filings and a listing on the NEX Exchange in August 2025, alongside ongoing emphasis on employer solutions for cancer outcomes through advanced diagnostics and nutritional partnerships like CareOncology with The Source Functional Nutrition.
Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST)
Fonar (NASDAQ:FONR) and Stagezero Life Sciences (OTCMKTS:SZLSF) Head-To-Head Comparison
Head-To-Head Review: Insulet (NASDAQ:PODD) and Stagezero Life Sciences (OTCMKTS:SZLSF)
Contrasting Stagezero Life Sciences (OTCMKTS:SZLSF) and TriSalus Life Sciences (NASDAQ:TLSI)
StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order
StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings
StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
StageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcript
StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q2 2022 Results - Earnings Call Transcript
StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting